In December 2021, China once again updated its National Reimbursed Drugs List (NRDL).
Read moreThis educational blog explores what PROs are, explains why they of growing importance in the digital...
Read moreAdvanced therapy medicinal products (ATMPs) are medicinal products for human use that are based on l...
Read moreNICE require a broad range of evidence to be included within the reimbursement dossier, including cl...
Read moreThis reforms have been welcomed by the industry as they should support faster access to medicines as...
Read moreThe 2021 Social Security Law made provision for overhauling the early scheme in France. As of 1st Ju...
Read moreWe hope you’ve had a wonderful start to the New Year and we’d love to welcome you to our fourth ...
Read moreAccording to the Institute for Quality and Efficiency in Health Care orphan drugs should undergo a r...
Read moreAs we enter 2022, we are approaching the two-year anniversary of the COVID-19 pandemic spreading acr...
Read moreReviewing previous HTA submissions can provide valuable insights that can help manufacturers prepare...
Read more